{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T22:21:03Z","timestamp":1785450063820,"version":"3.56.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009169","name":"Assiut University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009169","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Epicardial and pericardial adipose tissues are two distinct types of visceral fat in close adherence to the heart and were found to be increased among diabetics.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Aim<\/jats:title>\n            <jats:p>To investigate the correlation between cardiac magnetic resonance (CMR)-quantified epicardial (EFV) and pericardial fat (PFV) volumes and the complexity of coronary artery disease (CAD) among diabetic and non-diabetic patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This was a cross-sectional study that included 111 patients having CAD as indicated by coronary angiography and who underwent CMR. Epicardial and pericardial fat volumes were measured along short-axis CMR-derived images. CAD severity and complexity were evaluated using the syntax score (SS). Patients were classified into diabetic and non-diabetic groups based on their HbA1c and were compared regarding clinical, angiographic, and CMR data. Those with high SS were compared against low\/intermediate SS. The correlation of measured EFV and PFV with the SS was evaluated, and possible predictors for high-SS were assessed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Diabetic patients (<jats:italic>n<\/jats:italic>\u2009=\u200964, 57.7%) had significantly high syntax scores, and significantly larger absolute and indexed EFV and PFV compared to non-diabetics. Both EFV and PFV showed a significant positive correlation with HbA1c and SS. EFV\u2009\u2265\u2009119.55\u00a0ml significantly predicted high-SS (AUC\u2009=\u20090.84, 95%CI\u2009=\u20090.76\u20130.91, sensitivity\u2009=\u200977% and specificity\u2009=\u200982.5%) among the study population. Different cutoff points of EFV significantly predicted high SS among diabetics and non-diabetics with respective reasonable sensitivity and specificity. Age and EFV were consistently predictive of high SS on different multivariable regression models.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Increased epicardial adipose tissue was a significant independent predictor of severe and complex CAD, representing a possible risk marker and potential therapeutic target, particularly among diabetics.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12933-025-02606-x","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T13:52:14Z","timestamp":1738936334000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Cardiac magnetic resonance quantified epicardial fat volume is associated with complex coronary artery disease among diabetics"],"prefix":"10.1186","volume":"24","author":[{"given":"Shimaa Sayed","family":"Khidr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bakeer Mohamed","family":"Bakeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatem Abdel-Rahman","family":"Helmy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba Mahmoud","family":"El-Naggar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,7]]},"reference":[{"key":"2606_CR1","doi-asserted-by":"publisher","first-page":"675","DOI":"10.36660\/abc.20190197","volume":"114","author":"H G\u00fcne\u015f","year":"2020","unstructured":"G\u00fcne\u015f H, G\u00fcne\u015f H, Temiz F. The relationship between epicardial adipose tissue and insulin resistance in obese children. Arq Bras Cardiol. 2020;114:675\u201382. https:\/\/doi.org\/10.36660\/abc.20190197.","journal-title":"Arq Bras Cardiol"},{"key":"2606_CR2","doi-asserted-by":"publisher","first-page":"e413","DOI":"10.1002\/mco2.413","volume":"4","author":"Y Song","year":"2023","unstructured":"Song Y, Tan Y, Deng M, Shan W, Zheng W, Zhang B. Epicardial adipose tissue, metabolic disorders, and cardiovascular diseases: recent advances classified by research methodologies. MedComm. 2023;4:e413. https:\/\/doi.org\/10.1002\/mco2.413.","journal-title":"MedComm"},{"issue":"20","key":"2606_CR3","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1016\/j.jacc.2018.03.509","volume":"71","author":"M Packer","year":"2018","unstructured":"Packer M. Epicardial adipose tissue may mediate deleterious effects of obesity and inflammation on the myocardium. J Am Coll Cardiol. 2018;71(20):2360\u201372.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2606_CR4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12933-017-0650-3","volume":"17","author":"J Kang","year":"2018","unstructured":"Kang J, Kim YC, Park JJ, Kim S, Kang SH, Cho YJ, et al. Increased epicardial adipose tissue thickness is a predictor of new-onset diabetes mellitus in patients with coronary artery disease treated with high-intensity statins. Cardiovasc Diabetol. 2018;17(1):10.","journal-title":"Cardiovasc Diabetol"},{"key":"2606_CR5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.4103\/jcecho.jcecho_22_19","volume":"29","author":"LA Leo","year":"2019","unstructured":"Leo LA, Paiocchi VL, Schlossbauer SA, Ho SY, Faletra FF. The intrusive nature of epicardial adipose tissue as revealed by cardiac magnetic resonance. J Cardiovasc Echogr. 2019;29:45\u201351. https:\/\/doi.org\/10.4103\/jcecho.jcecho_22_19.","journal-title":"J Cardiovasc Echogr"},{"issue":"1","key":"2606_CR6","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1515\/med-2022-0590","volume":"17","author":"JR Ulloque-Badaracco","year":"2022","unstructured":"Ulloque-Badaracco JR, Alarcon-Braga EA, Campos-Aspajo A, Hernandez-Bustamante EA, Alarcon-Braga EA, Mosquera-Rojas MD, Campos-Aspajo A, Salazar-Valdivia FE. Atherogenic index of plasma and coronary artery disease: a systematic review. Open Med. 2022;17(1):1915\u201326. https:\/\/doi.org\/10.1515\/med-2022-0590","journal-title":"Open Med"},{"key":"2606_CR7","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1093\/eurheartj\/ehad192","volume":"44","author":"N Marx","year":"2023","unstructured":"Marx N, Federici M, Sch\u00fctt K, M\u00fcller-Wieland D, Ajjan RA, Antunes MJ, et al. 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes: developed by the task force on the management of cardiovascular disease in patients with diabetes of the European Society of Cardiology (ESC). Eur Heart J. 2023;44:4043\u2013140. https:\/\/doi.org\/10.1093\/eurheartj\/ehad192.","journal-title":"Eur Heart J"},{"key":"2606_CR8","first-page":"219","volume":"1","author":"G Sianos","year":"2005","unstructured":"Sianos G, Morel M-A, Kappetein AP, Morice M-C, Colombo A, Dawkins K, et al. The SYNTAX score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention. 2005;1:219\u201327.","journal-title":"EuroIntervention"},{"key":"2606_CR9","unstructured":"Bar M, Sarkar B, Sarkar M, Bagchi PC, Goswami D, Mitra A. Correlation study of epicardial adipose tissue thickness with SYNTAX score. Eur J Cardiovasc Med. 2023;13."},{"key":"2606_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12968-021-00827-z","volume":"24","author":"WG Hundley","year":"2022","unstructured":"Hundley WG, Bluemke DA, Bogaert J, Flamm SD, Fontana M, Friedrich MG, et al. Society for cardiovascular magnetic resonance (SCMR) guidelines for reporting cardiovascular magnetic resonance examinations. J Cardiovasc Magn Reson. 2022;24:1\u201326. https:\/\/doi.org\/10.1186\/s12968-021-00827-z.","journal-title":"J Cardiovasc Magn Reson"},{"key":"2606_CR11","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.echo.2009.10.013","volume":"22","author":"G Iacobellis","year":"2009","unstructured":"Iacobellis G, Willens HJ. Echocardiographic epicardial fat: a review of research and clinical applications. J Am Soc Echocardiogr. 2009;22:1311\u20139.","journal-title":"J Am Soc Echocardiogr"},{"key":"2606_CR12","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1161\/circulationaha.107.743062","volume":"117","author":"GA Rosito","year":"2008","unstructured":"Rosito GA, Massaro JM, Hoffmann U, Ruberg FL, Mahabadi AA, Vasan RS, et al. Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham heart study. Circulation. 2008;117:605\u201313. https:\/\/doi.org\/10.1161\/circulationaha.107.743062.","journal-title":"Circulation"},{"key":"2606_CR13","doi-asserted-by":"publisher","first-page":"101006","DOI":"10.1016\/j.ijcha.2022.101006","volume":"40","author":"AR Van Meijeren","year":"2022","unstructured":"Van Meijeren AR, Ties D, de Koning M-SL, Van Dijk R, Van Blokland IV, Veloz PL, et al. Association of epicardial adipose tissue with different stages of coronary artery disease: a cross-sectional UK Biobank cardiovascular magnetic resonance imaging substudy. IJC Heart Vasc. 2022;40:101006. https:\/\/doi.org\/10.1016\/j.ijcha.2022.101006.","journal-title":"IJC Heart Vasc"},{"key":"2606_CR14","doi-asserted-by":"publisher","first-page":"E253","DOI":"10.1002\/oby.20149","volume":"21","author":"C Doesch","year":"2013","unstructured":"Doesch C, Streitner F, Bellm S, Suselbeck T, Haghi D, Heggemann F, et al. Epicardial adipose tissue assessed by cardiac magnetic resonance imaging in patients with heart failure due to dilated cardiomyopathy. Obesity. 2013;21:E253\u201361. https:\/\/doi.org\/10.1002\/oby.20149.","journal-title":"Obesity"},{"key":"2606_CR15","doi-asserted-by":"publisher","first-page":"204201882412295","DOI":"10.1177\/20420188241229540","volume":"15","author":"S Kotha","year":"2024","unstructured":"Kotha S, Plein S, Greenwood JP, Levelt E. Role of epicardial adipose tissue in diabetic cardiomyopathy through the lens of cardiovascular magnetic resonance imaging\u2013a narrative review. Ther Adv Endocrinol Metab. 2024;15:20420188241229540. https:\/\/doi.org\/10.1177\/20420188241229540.","journal-title":"Ther Adv Endocrinol Metab"},{"key":"2606_CR16","doi-asserted-by":"publisher","unstructured":"Fan W, Si Y, Xing E, Feng Z, Ding Z, Liu Y, Wei C, Tian Y, Zhang Y, Liu J, Sun L. Human epicardial adipose tissue inflammation correlates with coronary artery disease. Cytokine. 2023. https:\/\/doi.org\/10.1016\/j.cyto.2022.156119","DOI":"10.1016\/j.cyto.2022.156119"},{"issue":"16","key":"2606_CR17","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.3390\/diagnostics14161830","volume":"14","author":"S Simantiris","year":"2024","unstructured":"Simantiris S, Pappa A, Papastamos C, Korkonikitas P, Antoniades C, Tsioufis C, Tousoulis D. Perivascular fat: a novel risk factor for coronary artery disease. Diagnostics. 2024;14(16):1830. https:\/\/doi.org\/10.3390\/diagnostics14161830","journal-title":"Diagnostics"},{"key":"2606_CR18","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3390\/jcdd9080253","volume":"9","author":"Q Wang","year":"2022","unstructured":"Wang Q, Chi J, Wang C, Yang Y, Tian R, Chen X. Epicardial adipose tissue in patients with coronary artery disease: a meta-analysis. J Cardiovasc Dev Disease. 2022;9:253. https:\/\/doi.org\/10.3390\/jcdd9080253.","journal-title":"J Cardiovasc Dev Disease"},{"key":"2606_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-019-0807-3","volume":"18","author":"Y Li","year":"2019","unstructured":"Li Y, Liu B, Li Y, Jing X, Deng S, Yan Y, & She Q. Epicardial fat tissue in patients with diabetes mellitus: a systematic review and meta-analysis. Cardiovasc Diabetol. 2019;18:1\u201310. https:\/\/doi.org\/10.1186\/s12933-019-0807-3.","journal-title":"Cardiovasc Diabetol"},{"key":"2606_CR20","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12916-023-02836-4","volume":"21","author":"M Choy","year":"2023","unstructured":"Choy M, Huang Y, Peng Y, Liang W, He X, Chen C, et al. Association between epicardial adipose tissue and incident heart failure mediating by alteration of natriuretic peptide and myocardial strain. BMC Med. 2023;21:117. https:\/\/doi.org\/10.1186\/s12916-023-02836-4.","journal-title":"BMC Med"},{"key":"2606_CR21","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.jash.2016.01.009","volume":"10","author":"G Kimura","year":"2016","unstructured":"Kimura G. Importance of inhibiting sodium-glucose cotransporter and its compelling indication in type 2 diabetes: pathophysiological hypothesis. J Am Soc Hypertens. 2016;10:271\u20138. https:\/\/doi.org\/10.1016\/j.jash.2016.01.009.","journal-title":"J Am Soc Hypertens"},{"key":"2606_CR22","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/oby.21718","volume":"25","author":"G Iacobellis","year":"2017","unstructured":"Iacobellis G, Mohseni M, Bianco SD, Banga PK. Liraglutide causes large and rapid epicardial fat reduction. Obesity. 2017;25:311\u20136. https:\/\/doi.org\/10.1002\/oby.21718.","journal-title":"Obesity"},{"key":"2606_CR23","doi-asserted-by":"publisher","first-page":"qyae057","DOI":"10.1093\/ehjimp\/qyae057","volume":"14","author":"J Bialobroda","year":"2024","unstructured":"Bialobroda J, Bouazizi K, Ponnaiah M, Kachenoura N, Charpentier E, Zarai M, et al. The adipose tissue confined in the atrio-ventricular groove can be used to assess atrial epicardial adipose tissue and atrial dysfunction during cardiac magnetic resonance imaging. Eur Heart J Imaging Methods Pract 2024;14:qyae057. https:\/\/doi.org\/10.1093\/ehjimp\/qyae057.","journal-title":"Eur Heart Journal-Imaging Methods Pract Jun"},{"issue":"8","key":"2606_CR24","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.jchf.2020.06.003","volume":"8","author":"TM Gorter","year":"2020","unstructured":"Gorter TM, Woerden GV, Rienstra M, et al. Epicardial adipose tissue and invasive hemodynamics in heart failure with preserved ejection fraction. JACC Heart Fail. 2020;8(8):667\u201376. https:\/\/doi.org\/10.1016\/j.jchf.2020.06.003.","journal-title":"JACC Heart Fail"},{"key":"2606_CR25","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1186\/s12933-024-02517-3","volume":"23","author":"Y Xu","year":"2024","unstructured":"Xu Y, Duo J, Li Y, Wang S, Wan K, Li W, et al. Increased epicardial adipose tissue is associated with left ventricular reverse remodeling in dilated cardiomyopathy. Cardiovasc Diabetol. 2024;23:447. https:\/\/doi.org\/10.1186\/s12933-024-02517-3.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2606_CR26","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s12933-024-02298-9","volume":"23","author":"BJ Kasperova","year":"2024","unstructured":"Kasperova BJ, Mraz M, Svoboda P, et al. Sodium-glucose cotransporter 2 inhibitors induce anti-inflammatory and anti-ferroptotic shift in epicardial adipose tissue of subjects with severe heart failure. Cardiovasc Diabetol. 2024;23(1):223. https:\/\/doi.org\/10.1186\/s12933-024-02298-9.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2606_CR27","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s12933-024-02322-y","volume":"23","author":"A Ryk","year":"2024","unstructured":"Ryk A, Marcinkiewicz A, Chrzanowski J, et al. Cholesin receptor signalling is active in cardiovascular system-associated adipose tissue and correlates with SGLT2i treatment in patients with diabetes. Cardiovasc Diabetol. 2024;23(1):211. https:\/\/doi.org\/10.1186\/s12933-024-02322-y","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2606_CR28","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12933-023-01738-2","volume":"22","author":"AV Myasoedova","year":"2023","unstructured":"Myasoedova AV, Parisi V, Moschetta D, et al. Efficacy of cardiometabolic drugs in reduction of epicardial adipose tissue: a systematic review and meta-analysis. Cardiovasc Diabetol. 2023;22(1):23. https:\/\/doi.org\/10.1186\/s12933-023-01738-2.","journal-title":"Cardiovasc Diabetol"},{"key":"2606_CR29","doi-asserted-by":"publisher","first-page":"e13136","DOI":"10.1111\/obr.13136","volume":"22","author":"N Launbo","year":"2021","unstructured":"Launbo N, Zobel EH, von Scholten BJ, F\u00e6rch K, J\u00f8rgensen PG, Christensen RH. Targeting epicardial adipose tissue with exercise, diet, bariatric surgery or pharmaceutical interventions: a systematic review and meta-analysis. Obes Rev. 2021;22:e13136. https:\/\/doi.org\/10.1111\/obr.13136.","journal-title":"Obes Rev"},{"key":"2606_CR30","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1177\/10742484211006997","volume":"26","author":"EM Muzurovi\u0107","year":"2021","unstructured":"Muzurovi\u0107 EM, Vujo\u0161evi\u0107 S, Mikhailidis DP. Can we decrease epicardial and pericardial fat in patients with diabetes? J Cardiovasc Pharmacol Therap. 2021;26:415\u201336. https:\/\/doi.org\/10.1177\/10742484211006997.","journal-title":"J Cardiovasc Pharmacol Therap"},{"key":"2606_CR31","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.numecd.2023.10.016","volume":"34","author":"G Iacobellis","year":"2024","unstructured":"Iacobellis G, Goldberger JJ, Malavazos AE, Sterling CGM, Canturk A. Epicardial fat thickness in type 2 diabetes outpatient care. Nutr Metab Cardiovasc Dis. 2024;34:618\u201323. https:\/\/doi.org\/10.1016\/j.numecd.2023.10.016.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"2606_CR32","doi-asserted-by":"publisher","first-page":"32","DOI":"10.22122\/arya.v14i1.1552","volume":"14","author":"A Nasri","year":"2018","unstructured":"Nasri A, Najafian J, Derakhshandeh SM, Madjlesi F. Epicardial fat thickness and severity of coronary heart disease in patients with diabetes mellitus type II. ARYA Atheroscler. 2018;14:32. https:\/\/doi.org\/10.22122\/arya.v14i1.1552.","journal-title":"ARYA Atheroscler"},{"key":"2606_CR33","doi-asserted-by":"publisher","first-page":"1088961","DOI":"10.3389\/fcvm.2023.1088961","volume":"10","author":"X Jin","year":"2023","unstructured":"Jin X, Gao B, Zheng J, Wu X, Zhang N, Zhu L, et al. Impact of epicardial adipose tissue volume on hemodynamically significant coronary artery disease in Chinese patients with known or suspected coronary artery disease. Front Cardiovasc Med. 2023;10:1088961. https:\/\/doi.org\/10.3389\/fcvm.2023.1088961.","journal-title":"Front Cardiovasc Med"},{"key":"2606_CR34","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.21037\/qims-22-709","volume":"13","author":"W Yu","year":"2023","unstructured":"Yu W, Chen Y, Zhang F, Liu B, Wang J, Shao X, et al. Association of epicardial adipose tissue volume with increased risk of hemodynamically significant coronary artery disease. Quant Imaging Med Surg. 2023;13:2582. https:\/\/doi.org\/10.21037\/qims-22-709.","journal-title":"Quant Imaging Med Surg"},{"key":"2606_CR35","doi-asserted-by":"publisher","first-page":"1261215","DOI":"10.3389\/fcvm.2023.1261215","volume":"10","author":"L Yang","year":"2023","unstructured":"Yang L, Yu W, Wan P, Wang J, Shao X, Zhang F, et al. Epicardial fat volume, an independent risk factor for major adverse cardiovascular events, had an incremental prognostic value to myocardial perfusion imaging in Chinese populations with suspected or known coronary artery disease with a normal left ventricular ejection fraction. Front Cardiovasc Med. 2023;10:1261215. https:\/\/doi.org\/10.3389\/fcvm.2023.1261215.","journal-title":"Front Cardiovasc Med"},{"key":"2606_CR36","doi-asserted-by":"publisher","first-page":"204201882092882","DOI":"10.1177\/2042018820928824","volume":"11","author":"RH Christensen","year":"2020","unstructured":"Christensen RH, von Scholten BJ, Lehrskov LL, Rossing P, J\u00f8rgensen PG. Epicardial adipose tissue: An emerging biomarker of cardiovascular complications in type 2 diabetes? Ther Adv Endocrinol Metab. 2020;11:2042018820928824. https:\/\/doi.org\/10.1177\/2042018820928824.","journal-title":"Ther Adv Endocrinol Metab"},{"key":"2606_CR37","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1177\/2047487317717820","volume":"24","author":"RH Christensen","year":"2017","unstructured":"Christensen RH, Von Scholten BJ, Hansen CS, Heywood SE, Rosenmeier JB, Andersen UB, et al. Epicardial, pericardial and total cardiac fat and cardiovascular disease in type 2 diabetic patients with elevated urinary albumin excretion rate. Eur J Prev Cardiol. 2017;24:1517\u201324. https:\/\/doi.org\/10.1177\/2047487317717820.","journal-title":"Eur J Prev Cardiol"},{"issue":"4","key":"2606_CR38","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1097\/RTI.0000000000000470","volume":"35","author":"KG Kallianos","year":"2020","unstructured":"Kallianos KG, Lorca MC, Moraes GL, Devcic Z, Lobach I, Ordovas KG. Pericardial fat enhancement: new computed tomography biomarker influences the relationship between pericardial fat and coronary artery disease. J Thorac Imaging. 2020;35(4):270\u20135. https:\/\/doi.org\/10.1097\/RTI.0000000000000470","journal-title":"J Thorac Imaging"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02606-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-025-02606-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02606-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T13:52:17Z","timestamp":1738936337000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-025-02606-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,7]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2606"],"URL":"https:\/\/doi.org\/10.1186\/s12933-025-02606-x","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,7]]},"assertion":[{"value":"20 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research was conducted according to the World Medical Association Declaration of Helsinki. It received approval from the Assiut University Faculty of Medicine`s ethical review board (IRB number: 17101071) and was registered at ClinicalTrials.gov (NCT 04111198). The authors confirm that patient consent forms have been obtained for this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"64"}}